Family Practice News Digital Network ... and showed a nonsignificant trend toward a higher risk for colorectal cancer (CRC). No association was noted between CRC and thiazolidinedione (TZD), Dr. Siddharth Singh reported at the annual Digestive Disease Week. ... There was considerable ... and more »
MarketWatch (press release) Galvus� (vildagliptin) is a dipeptidyl peptidase-4 (DPP-4) inhibitor, a class of oral diabetes medications that enhance the body's natural ability to control blood sugar. The Galvus� (vildagliptin) safety and efficacy profile has been established in a ... and more »
RedOrbit The findings, which appear in the December 2012 issue of Experimental Biology and Medicine , demonstrate that sEH inhibition and PPARγ activation in combination had the greatest beneficial effects on the multi-disease features and progression of kidney ... and more »
Family Practice News Digital Network ... and showed a nonsignificant trend toward a higher risk for colorectal cancer (CRC). No association was noted between CRC and thiazolidinedione (TZD), Dr. Siddharth Singh reported at the annual Digestive Disease Week. ... There was considerable ...
MarketWatch (press release) Galvus� (vildagliptin) is a dipeptidyl peptidase-4 (DPP-4) inhibitor, a class of oral diabetes medications that enhance the body's natural ability to control blood sugar. The Galvus� (vildagliptin) safety and efficacy profile has been established in a ... and more »
Clinical Endocrinology News Digital Network ... and showed a nonsignificant trend toward a higher risk for colorectal cancer (CRC). No association was noted between CRC and thiazolidinedione (TZD), Dr. Siddharth Singh reported at the annual Digestive Disease Week. ... There was considerable ... and more »
CBS Local Previously, it was believed that both the activity and the side-effects of the only approved class of drugs used to treat insulin resistance, thiazolidinedione insulin sensitizers, were mediated through PPAR. It is now generally accepted that ... and more »
